Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study - Concepedia

Concepedia

Publication | Closed Access

Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study

42

Citations

17

References

2009

Year

Vedat Uygun, Gülsün Karasu, Dilara Öğünç, Akif Yeşilipek, Volkan Hazar

Pediatric Blood & Cancer

Abstract

PIP/TAZO treatment was as effective and safe as CEF monotherapy as an initial empirical regimen in pediatric cancer patients with fever and neutropenia.

References

	Year	Citations

Page 1